Dr. Gayle Diane Dramen, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1315 Hwy 25 So, Buffalo, MN 55313 Phone: 763-682-0276 |
Dr. Ronald Robin Mathisen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5549 35th St Ne, Buffalo, MN 55313 Phone: 763-682-9052 Fax: 763-782-8100 |
Eagan Eye Clinic Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 103 Center Dr Ste 100, Buffalo, MN 55313 Phone: 763-682-1282 |
David Turner Optometrist Medicare: Accepting Medicare Assignments Practice Location: 94 14th St Ne, Suite 3, Buffalo, MN 55313 Phone: 763-746-3391 Fax: 763-682-5899 |
Dr. Rodney A Melgard, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 103 Center Dr, Suite 100, Buffalo, MN 55313 Phone: 763-682-1282 |
Mathisen Optometry,llc Optometrist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5549 35th St Ne, Buffalo, MN 55313 Phone: 873-229-2235 |
Dr. Warren J Stoltman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 103 Center Dr, Suite 100, Buffalo, MN 55313 Phone: 763-682-1282 |
Buffalo Eye Clinic P A Optometrist Medicare: Not Enrolled in Medicare Practice Location: 103 Center Dr, Suite 100, Buffalo, MN 55313 Phone: 763-682-1282 Fax: 763-682-4205 |
News Archive
Pre-clinical trials - the stage at which medications or therapies are tested on animals like laboratory mice - is a crucial part of drug development. It's only then that scientists can assess benefits and side effects before a drug is administered to patients.
Marianjoy Rehabilitation Hospital's Medical Director of Pediatric Rehabilitation, Mary Keen, M.D., has been named one of Chicago's top doctors by Chicago Magazine. Dr. Keen is active in patient care, research and education at Marianjoy, focusing much of her work with children who have cerebral palsy, developmental problems, brain injuries and autism.
After a spinal cord injury a number of factors impede the regeneration of nerve cells. Two of the most important of these factors are the destabilization of the cytoskeleton and the development of scar tissue.
United Cannabis Corporation today announced that it moved its provisional patent application to the next phase by filing a utility patent application related to the unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer with the U.S. Patent and Trademark Office.
Scientists warn health systems could face "overwhelming" costs of treating mental illness if no new money is invested in research.
› Verified 1 days ago